Treatment of wounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/519 (2006.01) A61K 31/496 (2006.01) A61K 31/505 (2006.01) A61K 38/49 (2006.01) A61K 45/06 (2006.01) A61P 1/04 (2006.01)

Patent

CA 2415791

This invention relates to the use of cyclic guanosine 3', 5'-monophosphate type five (cGMP PDE5) inhibitors (hereinafter PDE5 inhibitors), including in particular the compound sildenafil, for the treatment of chronic wounds of a non-diabetic origin including in particular chronic venous ulcers, chronic decubitus (pressure sores ) and arterial ulcers; and acute wounds.

L'invention se rapporte à l'utilisation d'inhibiteurs de la guanosine 3'5'-monophosphate cyclique de type cinq (cGMP PDE5) (ci-après dénommés inhibiteurs PDE5), y compris, en particulier, le composé sildenafil, pour le traitement de blessures chroniques d'origine non diabétique (notamment les ulcères veineux chroniques, les ulcères de décubitus chroniques (plaies de lit) et les ulcères artériels), et de blessures aiguës.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of wounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of wounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of wounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1978017

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.